Medical Implants Market Size, Share, Trends and Forecast 2026 to 2035

Medical Implants Market Size

Medical Implants Market Size reached US$ 126.26 Billion in 2025 and is expected to reach US$ 260.03 Billion by 2035, growing at a CAGR of 7.5% during the forecast period 2026-2035.

The global demand for medical implants is growing rapidly, driven by advancements in medical technology and the rising prevalence of chronic diseases. For instance, according to the American Medical Association, one in 10 Americans (about 10% of Americans) will have a medical device implanted into their bodies at some point in their lifetimes. Key factors driving this demand include the increasing geriatric population, the prevalence of conditions like cardiovascular diseases and arthritis, and advancements in biomaterials and minimally invasive surgical techniques.

Key Takeaways

• The medical implants market is projected to expand from USD 126.26 billion in 2025 to USD 260.03 billion by 2035, reflecting sustained investment across orthopedic, cardiovascular, dental, and neurological implant technologies.
• Orthopedic implants account for 24.68% of total market revenue, driven by rising musculoskeletal disorders and an aging population.
• North America leads the industry with 42.19% market share, benefiting from advanced healthcare infrastructure, strong reimbursement environments, and continuous product innovation.
• Asia-Pacific holds 20.25% market share while recording the fastest expansion due to increasing healthcare investments, local manufacturing, and broader adoption of minimally invasive procedures.
• Personalized implants produced through 3D printing are improving surgical precision while reducing production waste and manufacturing lead times.
• Premium implant pricing remains a challenge for healthcare systems, particularly in emerging economies where affordability influences treatment adoption.
• Major manufacturers continue to prioritize FDA approvals, smart implant technologies, biodegradable materials, and digital health integration to strengthen long-term competitive advantage.

Market Scope

For more details on this report – Request for Sample

Medical Implants Market Dynamics: Drivers & Restraints

Rising technological advancements are significantly driving the medical implants market growth

Biomaterials such as biopolymers and biodegradable implants are being increasingly used due to their biocompatibility, strength, and durability. These implants reduce the risk of immune responses and improve patient acceptance of implants. Thus, market players are developing advanced implants, which are driving market growth.

For instance, in August 2024, Stryker launched a first-of-its-kind biodegradable subacromial balloon implant, InSpace, the first balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs), in India. InSpace provides a new option for surgeons in their shoulder continuum of care that allows them to better meet the needs of their patients. The InSpace balloon implant is designed to restore the subacromial space without requiring sutures or fixation devices and has been demonstrated to improve shoulder motion and function.

3D printing has revolutionized the production of implants by allowing customization based on patient-specific anatomical needs. This technology improves surgical outcomes by creating precise, complex, and tailored implants that fit better and are more effective. The market for 3D-printed implants is expected to grow due to its ability to produce cost-effective, customizable solutions with shorter lead times. The advancements in 3D-printed implants are driving the market growth. 

For instance, in April 2024,  3D Systems announced the Food and Drug Administration (FDA) 510(k) clearance for its 3D-printed, patient-specific cranial implant solution, VSP PEEK Cranial Implant. VSP PEEK Cranial Implant includes a complete FDA-cleared workflow comprising segmentation and 3D modeling software, the 3D Systems EXT 220 MED 3D printer, Evonik VESTAKEEP i4 3DF PEEK (polyetheretherketone), and a pre-defined production process. This technology can produce patient-specific cranial implants with up to 85% less material than similar implants produced by traditional machining, which can lead to significant cost savings for an expensive raw material like implantable PEEK.

The high cost of the implants is hampering the growth of the medical implants market 

The high cost of medical implants significantly hampers the growth of the market by limiting access, especially in low-income regions and among economically disadvantaged patients. High-end implants, such as orthopedic joint replacements, often use expensive materials like titanium alloys and ceramics, which are costly to manufacture and purchase. This increases the initial price of the implant, making it unaffordable for many patients and healthcare systems.

For instance, according to the Journal of Orthopaedic Business, the mean cost of the standard knee implant was $5,336 ± $1,671, and the mean total cost of primary total knee arthroplasty (TKA) was $23,907 ± $9,514. The cost of the standard knee implant contributes to 22.3% of the total cost of a primary total knee arthroplasty.

The high cost of implants creates an economic burden on healthcare systems. In countries like the U.S., a significant portion of healthcare spending is directed toward high-cost procedures involving implants. This can lead to higher insurance premiums and out-of-pocket expenses for patients, affecting overall market growth. 

For instance, dental implants cost between $3000 and $7000 for one tooth. This price includes the implant itself, which is the titanium post that’s surgically placed into the jawbone, as well as the abutment and the crown. The crown, usually made of porcelain or zirconia, mimics the natural tooth’s look and function. 

Market Opportunities

Investment opportunities are expanding beyond conventional implant manufacturing toward intelligent, digitally connected medical devices. Companies capable of integrating sensors, artificial intelligence, remote monitoring, and personalized manufacturing into implant platforms are expected to create additional value for hospitals and clinicians.

Medical device manufacturers can also benefit from localized production strategies across Asia-Pacific, where healthcare infrastructure investments, expanding middle-class populations, and increasing surgical volumes are creating attractive commercialization opportunities.

Suppliers specializing in advanced biomaterials, implant coatings, additive manufacturing technologies, and surgical navigation systems are positioned to participate in the broader implant ecosystem as healthcare providers increasingly seek integrated treatment solutions.

Medical Implants Market Segment Analysis

The global medical implants market is segmented based on product type, material, application, end-user, and region.

The orthopedic implants from the product type segment are expected to hold 24.68% of the market share 

As the population ages, there is a rise in conditions like arthritis, osteoporosis, and fractures due to falls, leading to higher demand for implants such as joint replacements and spinal devices. For instance, according to the Bone and Joint Burden Organization, roughly one in four (24.5%) musculoskeletal diseases occurs in persons aged 65 years and older. Almost 40% of musculoskeletal diseases occur among persons aged 45 to 64 years, increasing demand for orthopedic implants.

Advances in orthopedic implants have enabled the development of customized implants that are more precise and better suited to individual patient anatomies. This has improved outcomes and reduced recovery times for procedures such as hip and knee replacements. For instance, in April 2024, Onkos Surgical announced that the U.S. Food & Drug Administration (FDA) granted a De Novo approval for its novel antibacterial-coated implants. Bacterial contamination of a permanent implant may have devastating effects, particularly in orthopedic oncology and revision arthroplasty applications where the patient population is highly vulnerable.

Major players in the orthopedic implants market, such as Johnson & Johnson, Stryker, and Zimmer Biomet, are driving growth through continuous innovation and the acquisition of smaller companies with advanced technologies. Their extensive product portfolios covering joint replacement systems, spine implants, and trauma devices are pivotal in maintaining dominance in the market.

For instance, in December 2024, Zimmer Biomet Holdings, Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona SoluTion Porous Plasma Spray (PPS) Femur, a total knee implant component offering an alternative for patients with sensitivities to bone cement and/or metal. The Persona SoluTion PPS Femur features a porous coating for cementless fixation and leverages a proprietary surface treatment designed to enhance wear performance.

Medical Implants Market Geographical Analysis

North America is expected to dominate the global medical implants market with a 42.19% share 

North America, particularly the United States, boasts a highly developed healthcare system with access to advanced medical technologies and skilled healthcare providers. The presence of well-equipped hospitals and specialized treatment centers facilitates the adoption of new medical implants. For instance, according to the American Academy of Implant Dentistry, in the US, over a million are treated with dental implants each year (corresponding to 2.5 million implants).

North America is a hub for medical research and innovation. The collaboration between academic institutions, healthcare providers, and industry leaders accelerates the development of advanced medical implants. Companies like Medtronic, Johnson & Johnson, Boston Scientific and other emerging players are headquartered in the United States, where they conduct extensive R&D to develop cutting-edge medical devices. This environment supports the launch of new products and technologies, thereby maintaining North America’s market dominance.

For instance, in December 2024, Mentor Worldwide LLC, part of Johnson & Johnson MedTech, announced the U.S. Food and Drug Administration (FDA) approved MENTOR MemoryGel Enhance Breast Implants for primary and revision reconstruction breast surgery in post-mastectomy women. This first-of-its-kind silicone gel-filled implant line features an expanded range of base widths, projections, and volumes in an entirely new range of sizes extending from 930 cc to 1445 cc, the largest on the market.

Asia-Pacific is growing at the fastest pace in the medical implants market, holding 20.25% of the market share 

The adoption of advanced technologies such as 3D printing, minimally invasive surgical techniques, and smart implants is growing in the APAC region, especially in Japan, China, and India. These technologies allow for customized implants by market players, better surgical outcomes, and quicker recovery times, which are especially attractive in densely populated regions with a high demand for cost-effective treatments.

For instance, in September 2024, GC Aesthetics, a leading medical technology company committed to advancing women’s health through innovative aesthetic and reconstructive breast solutions, launched the YOUTHLY brand in China, featuring its latest breast implant innovations: PERLE, Luna XT, and the latest version of The Round Collection, 100% filled.

The presence of global medical device manufacturers and increasing foreign direct investment in the healthcare sector are crucial factors. Companies like Zimmer Biomet (ZimVie), Medtronic, Johnson & Johnson, and Boston Scientific are expanding their footprint in APAC, either through local manufacturing facilities or distribution partnerships. These investments are boosting product availability and enabling quicker adoption of new medical technologies.

For instance, in February 2024, ZimVie Inc., a global life sciences leader in the dental and spine markets, launched TSX Implant in Japan. As ZimVie’s largest dental implant market in APAC and the fifth largest market globally, Japan is of great strategic importance to ZimVie. The launch of TSX in Japan allows the company to compete head-to-head with premium market leaders in the dental implant space. 

Medical Implants Market Major Players

The major global players in the medical implants market include Stryker Corporation, Dentsply Sirona, ZimVie Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., Smith+Nephew, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., Cochlear Ltd., and Wright Medical Group N.V., among others.

Recent Developments

• March 2026: Zimmer Biomet expanded its smart implant portfolio globally, introducing sensor-enabled orthopedic implants capable of real-time data tracking for post-surgical recovery and rehabilitation monitoring.
• February 2026: Straumann Group accelerated global deployment of next-generation dental implants with enhanced surface technology, improving osseointegration rates and reducing healing time in dental procedures.
• February 2026: Medtronic plc announced continued expansion of its next-generation implantable cardiac devices portfolio in the U.S., focusing on AI-enabled pacemakers and defibrillators with enhanced remote patient monitoring capabilities, improving post-implant outcomes and hospital connectivity.
• January 2026: Abbott Laboratories received expanded regulatory clearance in the U.S. for its implantable continuous glucose monitoring (CGM) systems, strengthening its diabetes care ecosystem and integrating implantable sensors with digital health platforms.

Industry Impact Analysis

Advances in additive manufacturing, AI-enabled implant monitoring, and biodegradable biomaterials are reshaping the competitive environment for medical implant manufacturers. Regulatory approvals for patient-specific implants are accelerating commercialization while encouraging greater investment in customized healthcare solutions.

At the same time, premium implant pricing remains an important consideration for healthcare providers. Manufacturers capable of balancing innovation with cost efficiency are likely to gain broader market acceptance across both developed and emerging healthcare systems.

Report Benefits

This report enables:

• Manufacturers to identify product innovation opportunities across implant categories.
• Investors to evaluate long-term revenue potential and technology adoption trends.
• Healthcare providers to understand future purchasing priorities and clinical adoption patterns.
• Procurement teams to assess supplier capabilities, product differentiation, and pricing considerations.
• Medical technology companies to benchmark competitive strategies and identify expansion opportunities.
• Corporate strategy teams to evaluate regional investment priorities through 2035.

Target Audience

• Medical Device Manufacturers
• Hospital Networks
• Specialty Clinics
• Ambulatory Surgical Centers
• Healthcare Investors
• Venture Capital Firms
• Procurement Managers
• Product Development Teams
• Regulatory Affairs Professionals
• Healthcare Distributors
• Government Healthcare Agencies
• Medical Technology Companies
• Research Organizations
• Strategic Consulting Firms

Conclusion

The medical implants market presents sustained commercial opportunities as healthcare systems continue prioritizing personalized treatment, minimally invasive surgery, and long-term patient outcomes. Advances in biomaterials, additive manufacturing, smart implant technologies, and digital health integration are expanding the clinical value of implantable devices while creating new revenue opportunities for manufacturers.

Although high procedure costs and affordability remain important considerations, continued innovation, expanding surgical volumes, favorable demographic trends, and increasing healthcare investments are expected to support long-term market expansion. Companies that combine technological innovation with scalable manufacturing, regulatory expertise, and strong clinical evidence will be best positioned to capitalize on demand through 2035.